(Q40562200)

21 September 2017

title

Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection (English)

1 reference

21 September 2017

A B J Groeneveld

1

1 reference

21 September 2017

A N Tacx

2

1 reference

21 September 2017

A W J Bossink

3

1 reference

21 September 2017

G J van Mierlo

4

1 reference

21 September 2017

C E Hack

5

1 reference

21 September 2017

publication date

1 February 2003

1 reference

21 September 2017

number of pages

10

1 reference

inferred from page(s)

published in

Clinical Immunology

1 reference

21 September 2017

volume

106

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

106-115

1 reference

Fever in hospitalized patients. With special reference to the medical service

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Local Pseudomonas instillation induces contralateral lung injury and plasma cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

The value of immune modulating parameters in predicting the progression from peritonitis to septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Serum Cytokine Levels in Human Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Secretory non-pancreatic phopholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Sepsis and serum cytokine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Complement activation in patients with sepsis is in part mediated by C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Protective effects of C5a blockade in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Role of C5a in multiorgan failure during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Lipid mediators in the pathophysiology of critical illness

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

The effect of C1-esterase inhibitor in definite and suspected streptococcal toxic shock syndrome. Report of seven patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Immunological therapy of sepsis: experimental therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Prediction of mortality in febrile medical patients: How useful are systemic inflammatory response syndrome and sepsis criteria?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Local inflammatory responses following bronchial endotoxin instillation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Anti-TNF treatment of baboons with sepsis reduces TNF-alpha, IL-6 and IL-8, but not the degree of complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Role of the classical pathway of complement activation in experimentally induced polymicrobial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Phospholipase A2 from plasma of patients with septic shock is associated with high-density lipoproteins and C3 anaphylatoxin: some implications for its functional role

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Both C3a and C3a(desArg) regulate interleukin-6 synthesis in human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Gender differences in human sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

10.1016/S1521-6616(02)00025-6

Identifiers

DOI

1 reference

21 September 2017

1 reference